Esperion Therapeutics, Inc. · NASDAQ:ESPR

Wasatch Advisors LP reported a 5.50% stake in Esperion Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 7, 2025

Wasatch Advisors LP reported a 5.50% stake in Esperion Therapeutics, Inc., 10,931,257 shares, as a passive investor on Mar 31, 2025. Filed Apr 7, 2025 (Schedule 13G/A).

Stake
5.50%
Shares
10,931,257
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
WASATCH ADVISORS LP5.50%10,931,257

Source

View original at SEC

Related